Fundamental dimension Equity attribute | ELOAFPeer $0.011▲+37.50% Cap $4.94MP/E -0.8x QuantScore37/100 | BGACFLeader $0.00560.00% Cap $260.1KP/E -0.2x QuantScore43/100 | FLOCFPeer $0.14170.00% Cap $6.23MP/E -0.2x QuantScore22/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
60/100 |
62/100 |
53/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 15/100 | 20/100 | 3/100 |
Growth Revenue / earnings growth & margins | 5/100 | 24/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.8x | -0.2x | -0.2x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -45.8x | -17.4x | 42.1x |
Price / Sales | 2.6x | 0.0x | 0.1x |
Price / Free Cash Flow | -5.5x | 0.5x | -0.6x |
PEG ratio | 0.01 | -0.00 | -0.02 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | 0.57 (Distress) | -1.89 (Distress) | -1.91 (Distress) |
Total debt / equity | 0.58 | -1.23 | 52.00 |
Quick ratio | 0.3x | 0.2x | 0.2x |
Interest coverage | -2.0x | -2.1x | -1.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -15.0% | +23.4% |
Net income growth YoY | -104.5% | +27.8% | -27.5% |
Gross margin (TTM) | 25.3% | 36.4% | 37.3% |
Operating margin (FY) | -9.8% | -12.6% | -17.9% |
FCF margin (FY) | -46.8% | 5.8% | -11.9% |
5. Trailing price performancePrice change over period |
1M return | +37.5% | 0.0% | 0.0% |
3M return | +37.5% | 0.0% | 0.0% |
6M return | +37.5% | 0.0% | 0.0% |
Year to date | +37.5% | 0.0% | 0.0% |
1Y return | +37.5% | 0.0% | 0.0% |
3Y return | -93.9% | -89.4% | 0.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.7786 +6978.4% upside | $0.0348 +520.6% upside | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |